Company building new level of specialty field services, to benefit farmers and advance sustainable agriculture
ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the launch of ICLeaf, a revolutionary diagnostics tool, which will provide farmers with a personal prescription for maximizing yield. The tool measures 10 different elements in a leaf sample and then delivers accurate, real-time feedback and a recommendation regarding nutrient use.
The process begins with the collection of leaves from the targeted crop, which are then analyzed using unique technology. Results are rapidly available – within up to three days after initial sampling – versus several weeks using traditional methods, and the new tool is also more sustainable than traditional testing. It will allow farmers to make quick and data-driven decisions, based on the measurements, and enable them to take multiple samples each year and make immediate, in-season improvements.
ICLeaf is complementary to Crop Advisor, an optimized data-based crop nutrition plan, which provides customized fertilizer recommendations, based on type of crop, location and environmental conditions. This customer-focused solution is supported by professional agronomists, who offer personal guidance throughout the process.
“As a company focused on creating impactful solutions for humanity’s sustainability challenges in the global food, agriculture and industrial markets, we are proud to introduce our new and advanced Israeli technology, which will help farmers gain greater visibility into their fields and maximize yields,” said Elad Aharonson, president of Growing Solutions for ICL. “This unique specialty service will assist farmers in planning for optimum nutrient management, by timely identifying deficiencies and enabling them to use the right products at the right time to improve yields and increase sales.”
ICLeaf is currently available for grape, cotton, banana, tomato and pomegranate crops in India, with other crops being added. The revolutionary diagnostics tool was created at the Center for Fertilization and Plant Nutrition (CFPN), which was founded through a partnership between ICL and the Volcani Institute (Agricultural Research Organization ARO). The Volcani Institute is the research arm of the Israeli Ministry of Agriculture and leads in its field, with among the widest range of technologies and developments in advanced agriculture.
The digital technology suite – including the ICLeaf and Crop Advisor solutions, among others – was developed by Agmatix, an ICL owned digital ag startup, which developed the world’s first single engine designed to drive the agronomic innovation cycle from research and experimental data into meaningful and actionable insights. The Agmatix platform can read and interpret thousands of the different data points commonly used across the agricultural industry to help scientists, agronomists and farmers make actionable decisions.
About ICL
ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the global food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation, to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,000 people worldwide, and its 2021 revenues totaled approximately $7 billion.
For more information, visit ICL's website at www.icl-group.com.
To access ICL's interactive ESG report, please click here.
You can also learn more about ICL on Facebook, LinkedIn and Instagram.
Forward Looking Statements
This announcement contains statements that constitute forward‑looking statements, many of which can be identified by the use of forward‑looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate” and “potential,” among others.
Forward-looking statements appear in this press release and include, but are not limited to, statements regarding the company’s intent, belief or current expectations. Forward-looking statements are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, positioning, objectives and expectations, general economic, market and business conditions, supply chain and logistics disruptions, energy storage and electric vehicle growth, the potential for new COVID-19 variants, global unrest and conflict, governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, changes in environmental, tax and other laws or regulations and the interpretation thereof. As a result of the foregoing, readers should not place undue reliance on the forward‐looking statements contained in this press release concerning the timing of the transaction, or other more specific risks and uncertainties facing ICL, such as those set forth in the “Risk Factors” section of its Annual Report on Form 20-F filed on February 23, 2022, as such risk factors may be updated from time to time in its Current Reports on Form 6-K and other filings ICL makes with the U.S. Securities and Exchange Commission from time to time.
Forward-looking statements refer only to the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to publicly release any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221021005028/en/
Contacts
Investor and Press Contact – Global
Peggy Reilly Tharp
VP, Global Investor Relations
+1-314-983-7665
Peggy.ReillyTharp@icl-group.com
Investor and Press Contact - Israel
Adi Bajayo
ICL Spokesperson
+972-3-6844459
Adi.Bajayo@icl-group.com